Impact Factor
4.13
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.97
840 total citations
h5-index
36
h5 depth signal
Cited share
90.7%
117 of 129
Total citations
840
Citation footprint
Metric signal
6.91
External metric anchor
Self-citation
0.7%
6 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
147
China
86
Italy
83
India
44
United Kingdom
38
Citing Fields of Research
Genetics & Genomics
120
Oncology
109
Lung Cancer
96
Noncoding RNA
82
Immunology
54
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,162
Articles tracked across the journal lifetime
Indexed publication set
129
117 cited publications
Last 12 months
68
5.7 publications/month
Open access share
35.3%
24 OA publications in the last year
Leading citing country
United States
147 citing publications
Leading citing field
Genetics & Genomics
120 citing publications
Latest tracked publication
8 October 2026
10 recent records available
Coverage & Indexing History
v10n1, 2006-
v10n1, 2006-
Research Focus & Classification
Indexed Subjects
Oncology
Lung Cancer
Noncoding RNA
Genetics & Genomics
Neurodegenerative Disorders
Breast Cancer
Broad Categories
Clinical Laboratory Techniques
Molecular Biology
Pharmacology
Lung Cancer
Immunology
Hematology
Musculoskeletal Disorders
Noncoding RNA
Urology
MeSH Descriptors
Biomarkers
Genetic Therapy
Molecular Diagnostic Techniques
Pharmacogenetics
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1007/s40291-026-00874-1
Open DOI
Manganese-Enhanced Magnetic Resonance Imaging: From Translational Research to First-in-Human Trials in Oncology
03
04
DOI 10.1007/s40291-026-00881-2
Open DOI
Gadoquatrane: First Approval
05
06
07
DOI 10.1007/s40291-026-00882-1
Open DOI
Orca-T: First Approval
08
DOI 10.1007/s40291-026-00878-x
Open DOI
Rapid Ex Vivo Visualization of Laryngeal Tumors Using a Sprayable pH-Activatable Fluorophore
09
DOI 10.1007/s40291-026-00879-w
Open DOI
Amyloid-β PET Radioligands in Alzheimer’s Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring
Amyloid-β (Aβ) positron emission tomography allows direct in vivo visualization of insoluble fibrillar Aβ deposition and has been used to detect Alzheimer’s disease pathology across the clinical continuum, from preclinical stages to over...
10
DOI 10.1007/s40291-026-00876-z
Open DOI
Bridging Biomarker Testing to Biomarker-Driven Targeted Therapy: Real-World ESR1 Mutation Testing Patterns and Prevalence in ER+, HER2− Metastatic Breast Cancer
Background The estrogen receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer (MBC) treatment landscape continues to evolve with targeted therapy development. Estrogen receptor 1 (ESR1) testing is ...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Merger of: Molecular diagnosis; and: American journal of pharmacogenomics, continuing the numbering of the former.